Regeneron Pharmaceuticals Inc (REGN)
906.54
-0.78
(-0.09%)
USD |
NASDAQ |
Apr 24, 16:00
906.80
+0.26
(+0.03%)
After-Hours: 20:00
Regeneron Pharmaceuticals EPS Diluted (TTM): 34.75 for Dec. 31, 2023
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 34.75 |
September 30, 2023 | 35.06 |
June 30, 2023 | 37.83 |
March 31, 2023 | 36.80 |
December 31, 2022 | 38.24 |
September 30, 2022 | 47.43 |
June 30, 2022 | 50.10 |
March 31, 2022 | 70.60 |
December 31, 2021 | 72.08 |
September 30, 2021 | 62.63 |
June 30, 2021 | 55.69 |
March 31, 2021 | 35.33 |
December 31, 2020 | 30.67 |
September 30, 2020 | 27.36 |
June 30, 2020 | 25.83 |
March 31, 2020 | 19.90 |
December 31, 2019 | 18.46 |
September 30, 2019 | 18.68 |
June 30, 2019 | 17.99 |
March 31, 2019 | 21.13 |
December 31, 2018 | 21.30 |
September 30, 2018 | 15.65 |
June 30, 2018 | 13.80 |
March 31, 2018 | 12.32 |
December 31, 2017 | 10.32 |
Date | Value |
---|---|
September 30, 2017 | 11.01 |
June 30, 2017 | 9.96 |
March 31, 2017 | 8.31 |
December 31, 2016 | 7.74 |
September 30, 2016 | 6.89 |
June 30, 2016 | 6.44 |
March 31, 2016 | 6.44 |
December 31, 2015 | 5.51 |
September 30, 2015 | 5.13 |
June 30, 2015 | 4.04 |
March 31, 2015 | 3.20 |
December 31, 2014 | 3.15 |
September 30, 2014 | 3.05 |
June 30, 2014 | 3.57 |
March 31, 2014 | 3.51 |
December 31, 2013 | 3.80 |
September 30, 2013 | 7.02 |
June 30, 2013 | 7.49 |
March 31, 2013 | 7.40 |
December 31, 2012 | 6.61 |
September 30, 2012 | 1.95 |
June 30, 2012 | -0.45 |
March 31, 2012 | -1.84 |
December 31, 2011 | -2.44 |
September 30, 2011 | -2.03 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (TTM) Range, Past 5 Years
17.99
Minimum
Jun 2019
72.08
Maximum
Dec 2021
38.71
Average
35.33
Median
Mar 2021
EPS Diluted (TTM) Benchmarks
Vertex Pharmaceuticals Inc | 13.89 |
Eli Lilly and Co | 5.686 |
AbbVie Inc | 2.73 |
Amgen Inc | 12.49 |
Pfizer Inc | 0.36 |